about
Biosynthetic Polymers as Functional MaterialsNanodiamonds: The intersection of nanotechnology, drug development, and personalized medicineThe physiology of cardiovascular disease and innovative liposomal platforms for therapyMaterials to clinical devices: technologies for remotely triggered drug delivery.Nanotoxicity overview: nano-threat to susceptible populationsA specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeuticsIncreased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats.Micro- and Nanoparticles for Treating Cardiovascular Disease.Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies.Targeting delivery of Radix Ophiopogonis polysaccharide to ischemic/reperfused rat myocardium by long-circulating macromolecular and liposomal carriers.The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium.Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium.Localized targeting of biomaterials following myocardial infarction: a foundation to build onPolymeric scaffold aided stem cell therapeutics for cardiac muscle repair and regeneration.Therapeutic application of nanotechnology in cardiovascular and pulmonary regeneration.Developing injectable nanomaterials to repair the heartHow Can Nanotechnology Help to Repair the Body? Advances in Cardiac, Skin, Bone, Cartilage and Nerve Tissue RegenerationDrug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling.Nanoparticle delivery of mitoprotective agents to target ischemic heart disease.Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences.The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticles.Nanomaterials for Cardiac Myocyte Tissue Engineering.Research Spotlight: Functionalized nanoparticles for future cardiovascular medicine.Distribution of Systemically Administered Nanoparticles Reveals a Size-Dependent Effect Immediately following Cardiac Ischaemia-Reperfusion InjuryEnzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial InfarctionMultiscale technologies for treatment of ischemic cardiomyopathy.Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed.Getting Drugs Across Biological Barriers.Biomimicking Platelet-Monocyte Interactions as a Novel Targeting Strategy for Heart Healing.In Vivo Ischemia Detection by Luminescent Nanothermometers.BaTiO3-core Au-shell nanoparticles for photothermal therapy and bimodal imaging.Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide.Nanomaterials for treating cardiovascular diseases: A review.Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and ChallengesThe Chemistry of Bioconjugation in Nanoparticles-Based Drug Delivery System
P2860
Q26745443-816EC5BE-F1BB-47A2-990B-B03FA68A2BACQ26776095-D89E0C0D-F183-489E-8A11-6B8310430169Q27002949-FAEA3332-310A-42DD-9FF0-1A0E59BE1CBAQ27006108-EE8E6558-0623-4D8E-AAFA-100E47EFC035Q28383369-F45C21C7-2222-4244-A5A0-E859CDB94AEBQ30802055-A8BB2AB8-59D8-4FA1-A78C-435076667659Q34982390-5E0DAC02-99F1-4AAB-AD65-96ABAC54305AQ35801354-22F0DA36-2290-4364-90A2-E8719EBDFBE1Q35942474-5736A063-EE4A-4CFF-B2CF-03C3971FAD4CQ36094149-9C9FBA04-6A39-4C97-98C3-20396B192CD6Q36555535-8B447744-F7B8-4453-AFEE-19C0E0908E65Q36598388-DC4F2E63-8B7C-418C-8F81-18A4F076C6FDQ36711694-B5E4C07C-3489-4F32-BEA0-AB77C94EF8D7Q37170581-1E9EEE35-96A1-400F-A2F7-B0520C54812DQ38132088-1EB9666D-A7EE-4DD4-9BC4-10BEAE19D901Q38201046-F1AB15ED-9217-4BDA-B507-EC1659B1BC6FQ38416005-32CE3251-4FB5-4C6F-AF24-7C9C81D5191EQ38624448-6842D962-6F6D-44CD-89A5-0418CE6E3419Q38676235-81024876-4E1D-426A-A540-588E986607B1Q38676283-989DEEFA-7C26-4079-A187-C8895E59C42FQ38742092-7DA4ED1B-929D-434F-8772-6CFF844E65E3Q38775962-5189C2EA-4CDA-4A71-A4FD-5A8EEF4A7465Q38878171-A69ADB5C-1743-43E8-AE6B-491865158D75Q39196492-40950448-1A68-4B09-8CEB-1C379C5520D1Q39315471-2B9D79C9-6244-4D11-B991-042D1D1781CCQ41248810-C3D98ACB-997E-49D0-AC54-C0B0F852FA5CQ41295473-0F3280D2-DEFF-4221-BED2-B9DDD29428DDQ46454164-633FF453-72E5-4DB9-A366-6A8807B316A3Q48155889-F0A8CC81-A51A-4C5F-9DA4-034AD4F45A82Q48331228-5E3606F0-04AB-44E8-8392-BE1152EFA44BQ48957301-66F117F1-D8DE-414C-B2D9-A8C98670885AQ50263648-B1474C63-CCB7-4F31-9C89-8C60A1F5AA75Q51731536-01785178-878C-4D6F-B2C4-E216B314CD12Q52647641-5DE5646E-443E-4875-9EFB-2635F20F998FQ55026698-648C4C3F-3E52-4BD8-AEC8-369711B9B376Q57300051-4928523C-2BD1-43CD-BEE9-3576CAD0AD1FQ59101713-B003DDA4-9ACB-4E6F-864F-57EC93936DCF
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nanoparticles targeting the infarcted heart
@ast
Nanoparticles targeting the infarcted heart
@en
type
label
Nanoparticles targeting the infarcted heart
@ast
Nanoparticles targeting the infarcted heart
@en
prefLabel
Nanoparticles targeting the infarcted heart
@ast
Nanoparticles targeting the infarcted heart
@en
P2093
P2860
P356
P1433
P1476
Nanoparticles targeting the infarcted heart
@en
P2093
Daniel G Anderson
Daniel S Kohane
Jonathan H Tsui
Michael Bauer
Ronglih Liao
P2860
P304
P356
10.1021/NL2025882
P407
P577
2011-09-14T00:00:00Z